By Counterforce Health Team in Cerezyme (imiglucerase) —

How to Get Cerezyme (Imiglucerase) Covered by Cigna in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Cerezyme (Imiglucerase) Covered by Cigna in North Carolina

Yes, Cigna covers Cerezyme (imiglucerase) for Type 1 Gaucher disease with prior authorization. Your fastest path to approval requires: (1) confirmed Gaucher disease Type 1 diagnosis with enzyme testing and genetic confirmation, (2) specialist prescriber (hematologist/geneticist), and (3) complete PA submission with clinical documentation. First step today: Have your doctor submit Cigna's prior authorization form via CoverMyMeds or call Cigna directly. Standard decisions take 5 business days; expedited reviews take 24 hours for urgent cases. If denied, North Carolina's Smart NC external review process provides a binding appeal option within 120 days.

Table of Contents

  1. Coverage at a Glance
  2. Eligibility Triage: Do You Qualify?
  3. Step-by-Step: Fastest Path to Approval
  4. Required Documentation Checklist
  5. Common Denial Reasons & How to Fix Them
  6. Appeals Playbook for North Carolina
  7. Costs & Patient Assistance Programs
  8. Frequently Asked Questions

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for all Cerezyme prescriptions Cigna formulary documents Cigna PA Requirements
Formulary Tier Specialty medication tier Member portal or formulary Cigna Formulary
Diagnosis Required Confirmed Type 1 Gaucher disease Lab results and genetic testing FDA Label
Prescriber Requirement Specialist experienced in Gaucher disease Medical license verification Cigna Coverage Policy
Appeal Deadline 180 days for internal, 120 days for external Denial letter instructions NC DOI External Review

Eligibility Triage: Do You Qualify?

Likely Eligible ✅

You're likely eligible for Cerezyme coverage if you have:

  • Confirmed Type 1 Gaucher disease with low beta-glucocerebrosidase enzyme activity and genetic testing showing GBA1 mutations
  • Clinical manifestations like anemia, thrombocytopenia, bone disease, hepatomegaly, or splenomegaly
  • Specialist prescriber (hematologist, geneticist, or physician experienced in Gaucher disease)
  • Age 2 years or older (FDA-approved age range)

Possibly Eligible ⚠️

You may need additional documentation if:

  • Diagnosis is recent and you lack complete genetic confirmation
  • You're switching from another enzyme replacement therapy
  • Previous treatments haven't been well-documented
  • You need dosing outside the typical 2.5-60 units/kg range

Not Yet Eligible ❌

You'll need to address these issues first:

  • No confirmed Gaucher disease diagnosis
  • Enzyme testing shows normal levels
  • No specialist involvement in your care
  • Age under 2 years (pediatric considerations required)

Step-by-Step: Fastest Path to Approval

1. Confirm Your Diagnosis (Patient + Doctor)

What: Ensure you have both enzyme testing (beta-glucocerebrosidase assay) and genetic confirmation (GBA1 gene analysis). Timeline: 1-2 weeks if tests are needed Submit to: Your treating specialist Source: Gaucher Disease Testing Guidelines

2. Gather Required Clinical Documentation (Doctor)

What: Compile medical records showing clinical manifestations, prior treatments, and treatment goals. Timeline: 2-3 business days Documents needed: Lab results, imaging, previous therapy records Source: Cigna PA Form Requirements

3. Submit Prior Authorization (Doctor)

What: Complete Cigna's PA form with all required clinical information. How: Via CoverMyMeds, SureScripts, or fax to Cigna Timeline: Same day submission possible Source: Cigna PA Submission Process

4. Track Your Request (Patient)

What: Monitor PA status through Cigna member portal or by calling member services. Timeline: Check after 3 business days Contact: Number on your insurance card Source: Cigna Member Portal

5. Receive Decision (Patient + Doctor)

What: Cigna responds within 5 business days (24 hours for expedited). If approved: Pharmacy can fill prescription If denied: Move to appeals process Source: Cigna Coverage Decisions

Required Documentation Checklist

For Your Doctor to Include:

✅ Diagnosis Confirmation

  • Beta-glucocerebrosidase enzyme assay results (low activity)
  • Genetic testing showing GBA1 mutations
  • ICD-10 diagnosis code (E75.22 for Gaucher disease)

✅ Clinical Manifestations

  • Current lab values (hemoglobin, platelet count)
  • Imaging showing organomegaly if present
  • Bone disease documentation if applicable

✅ Treatment History

  • Previous Gaucher-specific therapies tried
  • Outcomes and any intolerance or contraindications
  • Rationale for Cerezyme specifically

✅ Prescriber Information

  • Medical license and specialty
  • Experience treating Gaucher disease
  • Contact information for peer-to-peer review

✅ Dosing Justification

  • Proposed dose within FDA-approved range (2.5-60 units/kg)
  • Dosing frequency (three times weekly to every two weeks)
  • Treatment goals and monitoring plan
From our advocates: In our experience, PA approvals happen fastest when the specialist includes a detailed letter explaining why Cerezyme is medically necessary for this specific patient, rather than just checking boxes on the PA form. One hematologist told us that including recent photos of lab trends and a clear treatment timeline helped secure approval in just 3 days.

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Required Documentation
"Diagnosis not confirmed" Submit enzyme and genetic testing Lab reports showing low beta-glucocerebrosidase, GBA1 mutation analysis
"Not medically necessary" Provide clinical evidence of disease manifestations Recent CBC, imaging, symptom documentation
"Prescriber not qualified" Specialist attestation or referral Medical license, board certification, Gaucher experience
"Dosing outside guidelines" Justify dose with clinical rationale FDA label reference, patient-specific factors
"Step therapy required" Document failure/contraindication to alternatives Prior therapy records, adverse event documentation

Appeals Playbook for North Carolina

If Cigna denies your Cerezyme request, North Carolina offers multiple appeal levels:

Internal Appeals (First Step)

Timeline: File within 180 days of denial Process: Submit appeal letter with additional clinical documentation Decision time: 15 calendar days (72 hours if expedited) How to file: Cigna member portal or fax to number on denial letter Source: Cigna Appeals Process

Peer-to-Peer Review

When to use: After initial PA denial, before formal appeal Who participates: Your prescribing doctor and Cigna medical director Timeline: Usually scheduled within 1 week of request Tip: Have your doctor prepare clinical guidelines and patient-specific rationale

Smart NC External Review (Final Step)

Timeline: File within 120 days of final internal denial Process: Independent clinical experts review your case Decision time: 45 days (4 days if expedited) Binding: If approved, Cigna must cover within 3 business days How to file: Smart NC External Review Form Help available: Call Smart NC at 855-408-1212 for assistance

At Counterforce Health, we help patients and clinicians navigate these exact scenarios by turning insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and creates point-by-point rebuttals using the right clinical evidence and payer-specific requirements.

Costs & Patient Assistance Programs

Manufacturer Support

Sanofi Genzyme Patient Assistance: Financial assistance for eligible patients Contact: 1-800-745-4447 Website: Verify current programs with Sanofi directly

Copay Assistance

Most specialty pharmacies offer copay support programs. Check with:

  • Accredo Specialty Pharmacy
  • CVS Specialty
  • Walgreens Specialty Pharmacy

Foundation Grants

National Gaucher Foundation: Provides emergency financial assistance Contact: National Gaucher Foundation

Frequently Asked Questions

Q: How long does Cigna prior authorization take for Cerezyme in North Carolina? A: Standard PA decisions take 5 business days. Expedited reviews (when medically urgent) take 24 hours. Your doctor can request expedited review if delays would harm your health.

Q: What if Cerezyme isn't on my Cigna formulary? A: You can request a formulary exception. Your doctor must document that formulary alternatives are ineffective or harmful for your specific condition. The process follows the same PA timeline.

Q: Can I get expedited appeals in North Carolina? A: Yes. Both Cigna internal appeals and Smart NC external reviews offer expedited options when delays could seriously jeopardize your health. Decisions come within 72 hours (internal) or 4 days (external).

Q: What happens if I move to North Carolina from another state? A: Your prior therapy history from other states counts toward step therapy requirements. Make sure your new doctor has complete records of previous treatments and outcomes.

Q: Does age affect Cerezyme coverage approval? A: Cerezyme is FDA-approved for patients 2 years and older. Pediatric patients may need additional documentation but generally face the same PA requirements as adults.

Q: How often do I need to renew prior authorization? A: Most Cigna approvals are valid for 12 months. Your doctor will need to resubmit documentation showing continued medical necessity and treatment response before the authorization expires.

When navigating these processes, remember that Counterforce Health specializes in helping patients get prescription drugs approved by turning denials into evidence-backed appeals that align with each payer's specific requirements.

Sources & Further Reading

Disclaimer: This guide provides general information about insurance coverage and appeals processes. It is not medical advice and should not replace consultation with your healthcare provider. Coverage policies and procedures may change. Always verify current requirements with Cigna and consult the official North Carolina Department of Insurance resources for the most up-to-date appeals information.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.